Tweetable abstract Mitochondria are increasingly a target for drug delivery in cardiovascular diseases. This editorial describes how a nanomedicine approach may improve drug potency and efficacy in a safe and controlled manner.
Journal article
Nanomedicine (Lond)
07/12/2023
adenosine triphosphate, heart failure, ischemia/reperfusion injury, mitochondria, nanoparticles, reactive oxygen species